adjuvant discovery has focused on toll like receptors, mutant toxins and viral and bacterial vectors. However, recent evidence suggests that nutritive components such as vitamins and a subclass of polyphenols ... have…
ineff ective conventional treatment for breast carcinoma, the nonviral gene delivery system has been proved to be an attractive alternative to breast carcinoma therapy. Methods In this work, we have ... respectively…
protection as well as the effi cient presentation of these epitopes to the immune system. Th e study initially involves the identifi cation of components of, immunogenic peptides (epitopes ... will be expressed and…
Approximately, 40% of the infected patients develop a chronic debilitating illness of the cardiac system, characterized by clinically irreversible and progres- sive tissue destruction, and myocardial hypertrophy…
numbers of CD8 T cells further, probably due to rapid neutralization of the live vector during subsequent boosts. In contrast archaeosomes given repetitively stimulated large numbers of OVA-specifi ... ector memory…
diagnosis of disease. Th e PA gene was cloned into the pMAL-c2X expression vector and transformed into E.coli DH5Ã?±. Th e expression of recombinant fusion protein (rMBP ... countries and occurs among animals and…
Canada, we are leading efforts in the development of novel lipid adjuvants and delivery systems. Archaeosomes, prepared from isoprenoid lipids extracted from archaea, are one such adjuvant in development. Archaeosomes…
role of IFNγ we have cloned and studied the effect of rIFNγ on immune system of Labeo rohita , which is one of the most economically important fresh water carp ... Labeo rohita in SSN-1 cell line was cloned and…
ecombinant influenza viruses are promising viral platforms to be used as antigen delivery vectors. To this aim, one of the most promising approaches consists to generate recombinant viruses harboring partially…
vaccinology. This approach will present the native structural proteins of HIV-1 to the immune system which strategy has proven effective for decades in the prevention of polio, influenza, rabies, hepatitis ... positive…
near future, there may be ?zero tolerance? towards antibiotic-based selection in production systems. Besides the antibiotic itself, the antibiotic resistance gene is an important consideration. The complete absence…
develop safe and effective live-virus vaccines coupled with a low-cost system of manufacture. Arbovax created a strategy based on the straightforward concept of developing stable mutations of arboviruses ... live…
formulation technologies. The ZH9 vector is very safe with attenuating mutations in genes for chrosimate synthase ( aroC ) and the type III secretion system ( ssaV ), and has been administered to over
deprived of some surface components and intracellular content constitute safe and efficient vaccine delivery vectors for heterologous proteins. There are two strategies used to present heterologous antigens on the…
would also have advantages. Methods: Here we report development of new synthetic optimized plasmid vector/improved EP encoding Abs genes for delivery in vivo . This strategy allows for in vivo ... well as in other…
been conducted testing the efficacy of candidate HIV/SIV vaccines delivered by different viral vectors (e.g. Ad5, CMV and others. Despite inducing comparable levels of T cell responses, immunization with ... infection…
south European countries could also has a potential impact in increasing the colonization by vector populations that were not native. Besides, in many countries at risk of infection, standard collaboration ... settled…
strains of Mycobacterium tuberculosis. This was achieved by first developing a cloning vector and transformation system for Amycolatopsis mediterranei followed by swapping the acyltransferase domain of module six ( AT6)…
infectious diseases or potential biological warfare agents are also under investigation. Plant virus expression vectors represent a technology that enables high levels of pharmaceutical proteins to be produced…
protein vaccine was made and purified using yeast Pichia pastoris pPIC9k/GS115 host-vector system. DNA version of the vaccine was prepared by incorporating the gene encoding
defective or overexpressing genes. Although viral vectors transfect cells efficiently, risks associated with their use limit their clinical applications1,2. Nonviral delivery systems are safer, easier to manufacture…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.